BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-19
DOI
10.1038/s41375-019-0540-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8+ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy
- (2019) Jooeun Bae et al. LEUKEMIA
- Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy
- (2018) Hyunjoon Kim et al. BIOMATERIALS
- Chimeric antigen receptor–modified T cells: CD19 and the road beyond
- (2018) Alexander I. Salter et al. BLOOD
- Stimuli Responsive Nanoparticles for Controlled Anti-cancer Drug Release
- (2018) Qi Tang et al. CURRENT MEDICINAL CHEMISTRY
- Designer T-cells and T-cell receptors for customized cancer immunotherapies
- (2018) Mateusz Legut et al. CURRENT OPINION IN PHARMACOLOGY
- CAR T-cell Therapy: A New Era in Cancer Immunotherapy
- (2018) Miliotou N. Androulla et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Application of E75 peptide vaccine in breast cancer patients: A systematic review and meta-analysis
- (2018) Reyhane Chamani et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine
- (2018) Sheikh Tasnim Jahan et al. International Journal of Nanomedicine
- Nanomedicine: An effective tool in cancer therapy
- (2018) Saima Aftab et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Therapeutic cancer vaccine: building the future from lessons of the past
- (2018) T. Tran et al. Seminars in Immunopathology
- In ovo administration of Toll-like receptor ligands encapsulated in PLGA nanoparticles impede tumor development in chickens infected with Marek’s disease virus
- (2018) Jegarubee Bavananthasivam et al. VACCINE
- Nanomedicines for developing cancer nanotherapeutics: from benchtop to bedside and beyond
- (2018) Javed Iqbal et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Recent insights into the development of nucleic acid-based nanoparticles for tumor-targeted drug delivery
- (2018) Anantha Lakshmi Buddolla et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Clinical translation of immunoliposomes for cancer therapy: recent perspectives
- (2018) Di Wang et al. Expert Opinion on Drug Delivery
- Nanomedicines for the treatment of hematological malignancies
- (2018) Anil K. Deshantri et al. JOURNAL OF CONTROLLED RELEASE
- Assessment of Safety and Immunogenicity of PVX-410 Vaccine With or Without Lenalidomide in Patients With Smoldering Multiple Myeloma
- (2018) Ajay K. Nooka et al. JAMA Oncology
- New Hope for Therapeutic Cancer Vaccines in the Era of Immune Checkpoint Modulation
- (2018) Michael A. Curran et al. Annual Review of Medicine
- Ovarian carcinoma biological nanotherapy: Comparison of the advantages and drawbacks of lipid, polymeric, and hybrid nanoparticles for cisplatin delivery
- (2018) Yingli Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Nanomedicine in cancer stem cell therapy: from fringe to forefront
- (2018) Nazish Tabassum et al. CELL AND TISSUE RESEARCH
- Rational design of nanoparticles towards targeting antigen-presenting cells and improved T cell priming
- (2017) Eva Zupančič et al. JOURNAL OF CONTROLLED RELEASE
- Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma
- (2017) Silvia R. Graziani et al. MEDICAL ONCOLOGY
- Chimeric antigen receptor T-cell therapies for lymphoma
- (2017) Jennifer N. Brudno et al. Nature Reviews Clinical Oncology
- Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
- (2017) Sattva S. Neelapu et al. Nature Reviews Clinical Oncology
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- T-cell receptor-engineered T cells for cancer treatment: current status and future directions
- (2017) Yu Ping et al. Protein & Cell
- Overcoming T. gondii infection and intracellular protein nanocapsules as biomaterials for ultrasonically controlled drug release
- (2017) M. S. Aw et al. Biomaterials Science
- Cellular Immunotherapy in B-Cell Malignancy
- (2017) Mark-Alexander Schwarzbich et al. Oncology Research and Treatment
- 1173OMAGRIT, A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF THE RECMAGE-A3 + AS15 CANCER IMMUNOTHERAPEUTIC AS ADJUVANT THERAPY IN PATIENTS WITH RESECTED MAGE-A3-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC)
- (2017) J.F. Vansteenkiste et al. ANNALS OF ONCOLOGY
- A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors
- (2016) Steven A. Limentani et al. BREAST CANCER RESEARCH AND TREATMENT
- Considerations for the combination of anticancer vaccines and immune checkpoint inhibitors
- (2016) Julius Strauss et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2016) Johan F Vansteenkiste et al. LANCET ONCOLOGY
- Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanoma
- (2016) Stephan Grabbe et al. Nanomedicine
- Poly-(lactic-co-glycolic-acid)-based particulate vaccines: Particle uptake by dendritic cells is a key parameter for immune activation
- (2015) A.L. Silva et al. VACCINE
- Peptide/protein vaccine delivery system based on PLGA particles
- (2015) Mojgan Allahyari et al. Human Vaccines & Immunotherapeutics
- Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients
- (2015) Neil L Berinstein et al. OncoImmunology
- High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine
- (2014) Takuro Saito et al. VACCINE
- A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside
- (2013) C. L.-L. Chiang et al. CLINICAL CANCER RESEARCH
- Regulatory Roles of the Tumor Necrosis Factor Receptor BCMA
- (2013) Christine M. Coquery et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
- (2013) Wim H.J. Kruit et al. JOURNAL OF CLINICAL ONCOLOGY
- Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
- (2013) Charles Butts et al. LANCET ONCOLOGY
- A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myeloma
- (2012) Jooeun Bae et al. BRITISH JOURNAL OF HAEMATOLOGY
- Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders
- (2011) Jooeun Bae et al. BRITISH JOURNAL OF HAEMATOLOGY
- Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen
- (2011) Vinay Saini et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Identification of novel myeloma-specific XBP1 peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma
- (2011) J Bae et al. LEUKEMIA
- Programming the magnitude and persistence of antibody responses with innate immunity
- (2011) Sudhir Pai Kasturi et al. NATURE
- Combination of immune stimulating adjuvants with poly(lactide-co-glycolide) microspheres enhances the immune response of vaccines
- (2011) Aiala Salvador et al. VACCINE
- Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen
- (2011) Young-Ran Lee et al. Immune Network
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation